Filing Details

Accession Number:
0001209191-12-034803
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-06-20 20:38:08
Reporting Period:
2012-06-19
Filing Date:
2012-06-20
Accepted Time:
2012-06-20 20:38:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1103390 Ardea Biosciences Inc. RDEA Pharmaceutical Preparations (2834) 943200380
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1202094 Kimberly Manhard 4939 Directors Place
San Diego CA 92121
Svp, Regulatory & Dev Ops No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-06-19 4,375 $5.95 14,575 No 4 M Direct
Common Stock Acquisiton 2012-06-19 2,906 $14.95 17,481 No 4 M Direct
Common Stock Acquisiton 2012-06-19 5,548 $15.69 23,029 No 4 M Direct
Common Stock Disposition 2012-06-19 12,829 $31.96 10,200 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2012-06-19 4,375 $0.00 4,375 $5.95
Common Stock Employee Stock Option (Right to Buy) Disposition 2012-06-19 2,906 $0.00 2,906 $14.95
Common Stock Employee Stock Option (Right to Buy) Disposition 2012-06-19 5,548 $0.00 5,548 $15.69
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2017-07-25 No 4 M Direct
9,595 2019-12-15 No 4 M Direct
0 2018-01-01 No 4 M Direct
Footnotes
  1. Includes 230 shares acquired under the Ardea Biosciences, Inc. 2000 Employee Stock Purchase Plan on June 12, 2012.
  2. 25% of the shares subject to the stock option vest and become exercisable on July 26, 2008. The remaining shares vest in equal monthly installments over the following 3 years.
  3. The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the Date of Grant (12/16/09).
  4. 25% of the shares subject to the stock option vest and become exercisable on January 1, 2009. The remaining shares vest in equal monthly installments over the following 3 years.